Industrial Alliance Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Industrial Alliance Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-54	Closed	-$39K	–	131
2023 Q2	$39K	Sell	54 -6,466	-99%	-$4.99M	0.02%	141
2023 Q1	$5.36M	Sell	6,520 -95	-1%	-$71.7K	0.15%	123
2022 Q4	$4.77M	Sell	6,615 -105	-2%	-$77.5K	0.13%	146
2022 Q3	$4.63M	Sell	6,720 -6,280	-48%	-$3.95M	0.14%	148
2022 Q2	$7.68M	Sell	13,000 -231	-2%	-$150K	0.22%	112
2022 Q1	$9.24M	Sell	13,231 -2,789	-17%	-$1.76M	0.22%	107
2021 Q4	$10.1M	Buy	+16,020	New	+$9.85M	0.23%	102

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Industrial Alliance Investment Management's REGN Position: Q3 2023 in Review

Industrial Alliance Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 54 shares — an estimated $39K sold.

Industrial Alliance Investment Management first reported a position in REGN in Q4 2021 and held it in 7 quarters. The position peaked at $10.1M in Q4 2021. 1,178 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

Industrial Alliance Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Industrial Alliance Investment Management sold 54 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $39K.
Industrial Alliance Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Industrial Alliance Investment Management's Regeneron Pharmaceuticals position peaked at $10.1M in Q4 2021.
1,178 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q3 2023, filed 15 Nov 2023.